While these models are useful for controlling confounding variables, future studies would benefit from testing more natural cancer models, for example, comparing MYCN amplified cell lines with MYCN non-amplified cell lines or patient-derived xenografts, which might serve as useful tools for assessing MYCN links to mitosis. This evidence concerns the gene MYCN and cancer.